Papillary Thyroid Carcinoma in Struma Ovarii

Devi, P Lekshmi; Aghighi, Maryam; Mikhail, Nagy

doi:10.7759/cureus.7582

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…21,22 For extremely rare cases such as carcinoid tumors and papillary thyroid transformations, neuroendocrine markers (chromogranin, synaptophysin, and CD56) and thyroid biomarkers (HBME-1, galectin-3, thyroglobulin, and Thyroid Peroxidase) are excellent immunohistochemistry stains, respectively. 9,[23][24][25] The optimal management of these malignant transformations is uncertain because of their rarity, and there is no gold standard and direct comparisons between treatment approaches. The rarity suggests a low likelihood of future prospective studies to determine the best treatment options.…”

Section: Discussionmentioning

confidence: 99%

Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study

2023

Acta Med Philipp

View full text Add to dashboard Cite

Background and Objective. Malignant transformation (MT) in mature cystic teratoma of the ovary (MCTO) is rare. This descriptive study primarily aims to determine the prevalence rate of MT in MCTO and describe clinicopathologic features, management, and prognosis of patients who developed this rare type of tumor and likewise deliver a review in the light of recent literature.Methods. This is a descriptive observational study of 22 patients with MT in MCTO at a Level 3 Tertiary Public Hospital in Baguio City, Philippines. The clinical and pathological records of each patient were reviewed. Descriptive statistics were used. Results.Between January 2016 to December 2020, of the 369 cases of mature cystic teratoma, 22 cases with malignant transformation were reported with an incidence of 6%. The mean age of diagnosis was 52 years, of which 70% are aged 50 years old and above. Fifty-nine percent (13/22) and 32% (7/22) of the cases were squamous cell carcinoma and mucinous adenocarcinoma, respectively. Very rarely, malignant transformations were carcinoid tumors (1) and follicular carcinoma (1). The most common reason for consult among patients is a palpable abdominal/ pelvic mass (45.5%). Around 60% percent of cases have an elevated CA-125 value with a mean level of 180 U/ml. Seventy-two percent of cases with malignant transformation measured 10 cm or more with the largest mean diameter of 13 cm. Five patients underwent fertility-sparing surgery. Fourteen had staging procedures. Twelve patients were at Stage I. Three were at Stage II. Four and three patients were at Stage III and IV, respectively. Ten patients received adjuvant platinum-based chemotherapy and nine patients warrant no treatment after surgery. The median survival time is 14 months. Conclusion.Although not common, malignant transformation in MCT should be considered in older patients with large tumor sizes and elevated CA-125 assessed as MCT in preoperative and intraoperative assessment. This ovarian malignancy suggests an aggressive behavior but complete resection with systematic staging and indicated adjuvant platinum-based chemotherapy may improve survival.

show abstract

Section: Discussionmentioning

confidence: 99%

Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study

2023

Acta Med Philipp

View full text Add to dashboard Cite

show abstract

Coexistence of Papillary Thyroid Carcinoma and Strumal Carcinoid Arising from Struma Ovarii in Pregnant Women: a Case Report and Review

Kim

Ryang

et al. 2023

Int J Thyroidol

View full text Add to dashboard Cite

Mature cystic teratomas (MCTs) of the ovary can occur at any age; however, the most common period is childbearing age, accounting for 10-20% of ovarian tumors and 85-97% of germ cell tumors. Differentiated thyroid cancers from MCTs in pregnant women are rare. A 32-year-old pregnant women presented with left ovarian mass revealed following a transabdominal ultrasonography performed to confirm pregnancy. After delivery, left ovarian cystectomy was performed and mass was examined by pathologists. The result of pathological examination was a combined papillary thyroid carcinoma (PTC) and stromal carcinoid from a mature teratoma. Thyroid ultrasonography was performed to check for accompanying thyroid cancer. Two nodules with no suspected malignancy were observed in both lobes and no other adjuvant therapy was administered. We would like to report this extremely rare case along with a literature review.

show abstract

Papillary Thyroid Carcinoma in Struma Ovarii

Cited by 2 publications

References 8 publications

Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study

Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study

Coexistence of Papillary Thyroid Carcinoma and Strumal Carcinoid Arising from Struma Ovarii in Pregnant Women: a Case Report and Review

Contact Info

Product

Resources

About